Investor Stock List
#7,643 by institutional money · ETF

Virtus Biotech Clinical Trials ETF (BBC)

Institutional ownership from Q3 2026 Form 13F filings

$39.77
0.00% today
Market closed. Prices as of Nov 20, 7:41 AM ET
13F holders
17 (−3)
Held by 13F filers, live
$13.1M
Shares held
329,523
Share of stock outstanding
n/a
Net buying in Q3 2026
−$1.9M
New positions / sold out
3 / 6

Largest holders

17 investors
InvestorSharesValue, live% of their portfoliovs Q2 2026
Kera Capital Partners, Inc.115,982$4.6M0.41%Added +15%
Wealth Enhancement Advisory Services, LLC75,708$3.0M<0.1%Added +10%
Citadel Advisors LLC
Ken Griffin
37,268$1.5M<0.1%Reduced −13%
Quantinno Capital Management LP26,926$1.1M<0.1%Added +17%
Susquehanna International Group, LLP23,649$941K<0.1%Reduced −39%
Militia Capital Management LLC23,356$929K0.14%Reduced −49%
LPL Financial LLC10,174$405K<0.1%Reduced −17%
Morgan Stanley8,404$334K<0.1%Reduced −44%
Osaic Holdings, Inc.5,236$208K<0.1%Added +17%
UBS Group AG2,079$83K<0.1%Reduced −1%
Dynamic Wealth Strategies, LLC500$20K<0.1%Reduced −46%
Federation des caisses Desjardins du Quebec110$4K<0.1%Unchanged
Royal Bank Of Canada65$3K<0.1%New
Compass Financial Management LLC49$2K<0.1%Reduced −91%
Allworth Financial LP10$398<0.1%Unchanged
Blue Trust, Inc.6$239<0.1%New
Citigroup Inc1$40<0.1%New